
Novo Nordisk's insulin degludec injection is now available in pharmacies nationwide.
A host of new inhalers for chronic obstructive pulmonary disease are nearing market entry.
NFL Hall of Famer and Super Bowl champion Mike Haynes seeks to spread awareness about prostate cancer following his fight with the disease.
Researchers seek to predict age-related responses to hepatitis B vaccination.
Handheld miniature microscope allows surgeons to see cancer at a cellular level.
Younger melanoma patients undergo indoor tanning more frequently than older women with melanoma.
Few MS patients are treated for depression through psychotherapy or pharmaceutical therapy.
Health officials in Arizona successfully created a campaign last year that raised HIV awareness and led many more residents to visit the state's resource page for HIV education, testing, and services.
Study finds passage of Affordable Care Act caused a spike in ER visits for young adults with mental illnesses and circulatory system disease.
Abraxane and gemcitabine evaluated in first-line patients with metastatic pancreatic cancer.
Centers for Medicare and Medicaid Services issues final ruling that seeks to rein in the growing cost of prescription drugs.
Inherited genetic markers in immune response pathways associated with melanoma survival.
Sirolimus shows promise in decreasing skin cancer risk among organ transplant patients.
Iron accumulation may precede more pronounced brain atrophy.
The expanded use of Opdivo and Yervoy includes patients with BRAF V600 wild-type mutation-positive unresectable or metastatic melanoma.
New method may offer safer alternative to target tumors and minimize awful side effects for cancer patients.
Researchers stress that no conclusions can be drawn yet about the safety of cannabis and cannabinoid research.
ART treatment results in higher CD4+ T-cell frequency, lower cellular activation, and higher proportions of naive T-cells.
Researchers find mechanism that enables cells to migrate in a specific tissue.
Evidence shows demyelination and neuroaxonal abnormalities occur in both the white and grey matter of MS patients.
Eli Lilly and Company and Incyte Corporation have submitted a new drug application to the FDA for the approval of oral once-daily baricitinib for the treatment of moderate to severe rheumatoid arthritis.
Partisan split found in those who believe America should devote more funds to global health care initiatives.
Researchers find cancer evolves in specific patterns that are predictable through the laws of nature.
Genetic modifications enhance local DNA repair and protection in cancer treatment.
Some patients with amyotrophic lateral sclerosis who received the stem cell therapy showed less progression and improved respiratory and motor functions.
Hepatitis C treatment with pegylated interferon alpha may lead to anti-interferon antibodies.
High-intensity interval training found to increase ’ maximum oxygen uptake and improve the heart recovery rate in RA patients.
ACOs combined for a total net savings of $411 million in 2014.
Aggressive surgery to remove all cancer cells followed by targeted chemotherapy shows potential to significantly improve ovarian cancer survival.
Top news of the week in cancer drug development and research.